Suppr超能文献

间充质基质细胞及其分泌组:骨骼肌再生的新治疗前景

Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration.

作者信息

Sandonà Martina, Di Pietro Lorena, Esposito Federica, Ventura Alessia, Silini Antonietta Rosa, Parolini Ornella, Saccone Valentina

机构信息

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Santa Lucia, Rome, Italy.

Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Front Bioeng Biotechnol. 2021 May 13;9:652970. doi: 10.3389/fbioe.2021.652970. eCollection 2021.

Abstract

Mesenchymal stromal cells (MSCs) are multipotent cells found in different tissues: bone marrow, peripheral blood, adipose tissues, skeletal muscle, perinatal tissues, and dental pulp. MSCs are able to self-renew and to differentiate into multiple lineages, and they have been extensively used for cell therapy mostly owing to their anti-fibrotic and immunoregulatory properties that have been suggested to be at the basis for their regenerative capability. MSCs exert their effects by releasing a variety of biologically active molecules such as growth factors, chemokines, and cytokines, either as soluble proteins or enclosed in extracellular vesicles (EVs). Analyses of MSC-derived secretome and in particular studies on EVs are attracting great attention from a medical point of view due to their ability to mimic all the therapeutic effects produced by the MSCs (i.e., endogenous tissue repair and regulation of the immune system). MSC-EVs could be advantageous compared with the parental cells because of their specific cargo containing mRNAs, miRNAs, and proteins that can be biologically transferred to recipient cells. MSC-EV storage, transfer, and production are easier; and their administration is also safer than MSC therapy. The skeletal muscle is a very adaptive tissue, but its regenerative potential is altered during acute and chronic conditions. Recent works demonstrate that both MSCs and their secretome are able to help myofiber regeneration enhancing myogenesis and, interestingly, can be manipulated as a novel strategy for therapeutic interventions in muscular diseases like muscular dystrophies or atrophy. In particular, MSC-EVs represent promising candidates for cell free-based muscle regeneration. In this review, we aim to give a complete picture of the therapeutic properties and advantages of MSCs and their products (MSC-derived EVs and secreted factors) relevant for skeletal muscle regeneration in main muscular diseases.

摘要

间充质基质细胞(MSCs)是存在于不同组织中的多能细胞,这些组织包括骨髓、外周血、脂肪组织、骨骼肌、围产期组织和牙髓。MSCs能够自我更新并分化为多种细胞谱系,并且由于其抗纤维化和免疫调节特性(这些特性被认为是其再生能力的基础),它们已被广泛用于细胞治疗。MSCs通过释放多种生物活性分子(如生长因子、趋化因子和细胞因子)发挥作用,这些分子既可以是可溶性蛋白质,也可以包裹在细胞外囊泡(EVs)中。从医学角度来看,对MSC分泌组的分析,尤其是对EVs的研究,因其能够模拟MSCs产生的所有治疗效果(即内源性组织修复和免疫系统调节)而备受关注。与亲代细胞相比,MSC-EVs可能具有优势,因为其特定的货物包含可生物转移至受体细胞的mRNA、miRNA和蛋白质。MSC-EV的储存、转移和生产更容易;并且其给药也比MSC治疗更安全。骨骼肌是一种适应性很强的组织,但其再生潜力在急性和慢性疾病状态下会发生改变。最近的研究表明,MSCs及其分泌组都能够通过增强肌生成来帮助肌纤维再生,有趣的是,它们可以作为治疗肌肉疾病(如肌肉萎缩症或肌肉萎缩)的一种新策略进行调控。特别是,MSC-EVs是基于无细胞的肌肉再生的有希望的候选者。在这篇综述中,我们旨在全面介绍MSCs及其产物(源自MSC的EVs和分泌因子)在主要肌肉疾病中与骨骼肌再生相关的治疗特性和优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f94/8172230/dc05d5811fbc/fbioe-09-652970-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验